(Q55067888)

16 June 2018

title

Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group. (English)

1 reference

16 June 2018

main subject

premenstrual syndrome

1 reference

1 reference

0 references

Thys-Jacobs S

1

1 reference

16 June 2018

Starkey P

series ordinal

2

1 reference

16 June 2018

Bernstein D

series ordinal

3

1 reference

16 June 2018

Tian J

series ordinal

4

1 reference

16 June 2018

language of work or name

English

0 references

publication date

1 August 1998

1 reference

16 June 2018

American Journal of Obstetrics and Gynecology

published in

1 reference

16 June 2018

volume

179

1 reference

16 June 2018

issue

2

1 reference

16 June 2018

page(s)

444-452

1 reference

16 June 2018

cites work

Premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Lasting response to ovariectomy in severe intractable premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

The use of an LHRH agonist, buserelin, in the long-term management of premenstrual syndromes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Treatment of severe premenstrual syndrome with oestradiol patches and cyclical oral norethisterone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Calcium supplementation in premenstrual syndrome: a randomized crossover trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Dietary calcium and manganese effects on menstrual cycle symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

An association between osteoporosis and premenstrual symptoms and postmenopausal symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Clomipramine effectively reduces premenstrual irritability and dysphoria: a placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Fluoxetine treatment of severe premenstrual syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Hyperparathyroidism: neuropsychiatric manifestations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Psychiatric morbidity in primary hyperparathyroidism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

Serum and red cell magnesium levels in patients with premenstrual tension

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9378%2898%2970377-1

10.1016/S0002-9378(98)70377-1

7 January 2021

Identifiers

DOI

1 reference

16 June 2018

PubMed ID

9731851

1 reference

16 June 2018